Friday, February 24, 2017 10:41:49 PM
www.kens5.com/news/health/making-insulin-delivery-easier-and-less-painful/410139623
One in ten Texans is diabetic. Most of those who are treating the illness are forced to stick themselves with a needle several times a day. However, there are alternative treatments that are more convenient and less painful.
John Caldwell found out he was diabetic when he was just 16-years-old.
Charles Chavez had been pre-diabetic much of his life, but just recently became insulin-dependent after having his pancreas removed due to cancer. Neither of them have to deal with multiple insulin injections every day.
They each get their insulin in more convenient ways.
"Technology is getting better and better and allows you to live a fuller life, even though there's no cure on the horizon," said diabetes patient John Caldwell.
The technology Caldwell is talking about is the MiniMed 670G from Medtronic, which he has been testing in a clinical trial. It combines precise insulin delivery with continuous glucose monitoring into one system.
"It is constantly monitoring your glucose levels, and it's adjusting basal rates so that people with diabetes can achieve better control more safely with less mental burden," said Mike Hill, vice president of global marketing with Medtronic.
Caldwell said that mental burden can be embarrassing when you're in public.
"You have to stick yourself in the stomach. If you're comfortable enough, you do it in the restaurant booth. That could be a little bit awkward, especially with strangers."
With the MiniMed 670G, you wear it discreetly on your belt or underneath your clothes.
The pump connects to a very small delivery tube which attaches to the skin on your waist, with only one prick needed a week.
"When you see the shield that shows you the algorithm is working and the pump is automatically adjusting insulin based on your glucose levels," Hill said.
Caldwell said that constant monitoring is especially useful at night when he's sleeping.
"My wife Cheryl worries a lot less about me getting sick overnight because my glucose gets too low," said Caldwell.
Charles Chavez is still getting used to checking his glucose.
"On a regular basis, I have to monitor my blood glucose count before each meal," said Chavez, who is now insulin dependent after his pancreas removal.
He still has to inject himself with insulin at night, but the rest of the day, he uses an inhaler called Afrezza.
"What I like most about this insulin is it's a quicker onset of action, and it does not stay in your body too long. There is less risk of hypoglycemia," said endochrinologist Dr. Shahid Aziz.
It's also discreet.
"No one knows I'm taking insulin unless I tell them. Pop it open, drop in the little capsule, close it and inhale it," Chavez said.
"You don't have to go into the restroom or out in the parking lot and take the insulin out and inject. You can just take a small breath, inhale it and you are done," Aziz said.
Afrezza is available now, but not all insurance companies cover it.
The MiniMed 670G will be available this spring, but you can contact Medtronic now to get on their current system, the 630G, and get priority access to the new system for little to no cost.
Recent MNKD News
- MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease • GlobeNewswire Inc. • 05/06/2024 10:05:00 AM
- MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 08:00:00 PM
- MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases • GlobeNewswire Inc. • 04/30/2024 10:05:00 AM
- MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease • GlobeNewswire Inc. • 04/29/2024 10:05:00 AM
- MannKind Repays Certain Debt Obligations • GlobeNewswire Inc. • 04/03/2024 10:00:00 AM
- MannKind Announces CFO Transition • GlobeNewswire Inc. • 03/26/2024 08:05:00 PM
- INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps • GlobeNewswire Inc. • 03/11/2024 10:05:00 AM
- MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8 • GlobeNewswire Inc. • 03/05/2024 11:05:00 AM
- MannKind Corporation Announces Participation at Upcoming Conferences • GlobeNewswire Inc. • 03/04/2024 06:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:20 PM
- MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update • GlobeNewswire Inc. • 02/27/2024 09:00:00 PM
- MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024 • GlobeNewswire Inc. • 02/20/2024 11:00:00 AM
- MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza® • GlobeNewswire Inc. • 02/15/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:06:28 AM
- MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million • GlobeNewswire Inc. • 01/02/2024 11:05:00 AM
- MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/28/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2023 02:00:12 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/15/2023 09:09:12 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM